INVO Fertility Reports Third Quarter 2026 Results Highlighting 28% Clinic Revenue Growth and Continued Positive Clinic-Level Adjusted EBITDA
Globe Newswire•16/11/2026•09:08 ET
0
Key Highlights
- ➤Revenue $2.22M, up 26% year over year
- ➤Clinic revenue $2.21M, up 28% year over year
- ➤Net loss narrowed to $2.1M from $3.4M
- ➤Clinic-Level Adjusted EBITDA $292,114, seventh consecutive positive quarter
- ➤Current liabilities fell to $4.5M from $10.3M at year-end 2025
Expert Statements
Steve Shum, Chief Executive Officer of INVO Fertility
“Revenue grew again this quarter, and our clinics continued to generate positive Adjusted EBITDA before corporate expenses,”
Steve Shum, Chief Executive Officer of INVO Fertility
“We saw growth at our Wisconsin and Atlanta practices alongside the contribution from our acquisitions of the Indiana clinic and Birmingham clinic. That combination is what we set out to achieve by investing in our existing clinics and acquiring established practices.”
Steve Shum, Chief Executive Officer of INVO Fertility
“We continue to see increased opportunities for acquisitions, which remain a key component to our growth objectives, as independent fertility practices look for ways to serve more patients while preserving the local relationships that patients and physicians value.”
Steve Shum, Chief Executive Officer of INVO Fertility
“As a publicly traded fertility clinic operator, INVO provides public market investors an alternative way to participate directly in that evolution and share in the potential growth of our clinic network.”
Steve Shum, Chief Executive Officer of INVO Fertility
“Equally important, we have purposely made key investments in people and additional infrastructure, in advance, in preparation to expand our network.”
Steve Shum, Chief Executive Officer of INVO Fertility
“We believe we have assembled an excellent team capable of executing on our growth plans and we look forward to leveraging our infrastructure as we expand and driving further operating performance.”
Steve Shum, Chief Executive Officer of INVO Fertility
“Our balance sheet has also further strengthened in the period following the Wisconsin acquisition payment and the reduction in our current liabilities.”
Steve Shum, Chief Executive Officer of INVO Fertility
“We’re also focused on helping our clinics reach more patients and giving our clinical teams better tools and resources.”
Steve Shum, Chief Executive Officer of INVO Fertility
“Overall, the progress we’ve made and the opportunities we see on both sides of our growth strategy give us good reason to be excited about what comes next,”
Record quarterly clinic revenues supported by both organic growth and acquisitions
Seventh consecutive quarter of positive Clinic-Level Adjusted EBITDA
Get started
Create a free account to read the full story.
